Pharvinex Chempharm Profile
Key Indicators
- Authorised Capital ₹ 5.10 M
as on 09-11-2024
- Paid Up Capital ₹ 5.01 M
as on 09-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.47 Cr
as on 09-11-2024
- Satisfied Charges ₹ 5.10 M
as on 09-11-2024
- Revenue 105.50%
(FY 2023)
- Profit 57.31%
(FY 2023)
- Ebitda 159.21%
(FY 2023)
- Net Worth 131.08%
(FY 2023)
- Total Assets 159.54%
(FY 2023)
About Pharvinex Chempharm
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 M and a paid-up capital of Rs 5.01 M.
The company currently has active open charges totaling ₹8.47 Cr. The company has closed loans amounting to ₹5.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vagesh Tripathi, Shalu Jain, Kalpana Chaudhary, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299RJ2021PTC076257
- Company No.
076257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2021
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharvinex Chempharm?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vagesh Tripathi  | Director | 03-Aug-2021 | Current |
| Shalu Jain | Director | 03-Aug-2021 | Current |
| Kalpana Chaudhary | Director | 03-Aug-2021 | Current |
| Manish Jain | Director | 23-Oct-2021 | Current |
Financial Performance of Pharvinex Chempharm.
Pharvinex Chempharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.5% increase. The company also saw a substantial improvement in profitability, with a 57.31% increase in profit. The company's net worth Soared by an impressive increase of 131.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharvinex Chempharm?
Unlock access to Pharvinex Chempharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pharvinex Chemicals & Intermediates LlpActive 6 years 7 monthsVagesh Tripathi, Shalu Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 May 2024 | ₹2.70 M | Open |
Canara Bank Creation Date: 28 Feb 2024 | ₹5.50 Cr | Open |
Canara Bank Creation Date: 12 Sep 2022 | ₹2.70 Cr | Open |
How Many Employees Work at Pharvinex Chempharm?
Pharvinex Chempharm has a workforce of 36 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharvinex Chempharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharvinex Chempharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
